A three-drug combination to treat BRAF-mutant cancers

A new study that uses a triple-drug combination to overcome a major mechanism of drug resistance in cancer provides insights into the evolutionary paths taken by tumors in the face of selective pressure.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Sequential inhibition of BRAF pathway components is at a lower fitness threshold than simultaneous inhibition.

References

  1. 1

    Pratilas, C.A., Xing, F. & Solit, D.B. Curr. Top. Microbiol. Immunol. 355, 83–98 (2010).

    Google Scholar 

  2. 2

    Shi, H. et al. Nat. Commun. 3, 724 (2012).

    Article  Google Scholar 

  3. 3

    Larkin, J. et al. N. Engl. J. Med. 371, 1867–1876 (2014).

    Article  Google Scholar 

  4. 4

    Long, G.V. et al. N. Engl. J. Med. 371, 1877–1888 (2014).

    Article  Google Scholar 

  5. 5

    Xue, Y. et al. Nat. Med. 23, 929–937 (2017).

    CAS  Article  Google Scholar 

  6. 6

    Bock, C. & Lengauer, T. Nat. Rev. Cancer 12, 494–501 (2012).

    CAS  Article  Google Scholar 

  7. 7

    Brioli, A., Melchor, L., Cavo, M. & Morgan, G.J. Br. J. Haematol. 165, 441–454 (2014).

    Article  Google Scholar 

  8. 8

    Das Thakur, M. et al. Nature 494, 251–255 (2013).

    CAS  Article  Google Scholar 

  9. 9

    Skoulidis, F. & Papadimitrakopoulou, V.A. Clin. Cancer Res. 23, 618–622 (2017).

    CAS  Article  Google Scholar 

  10. 10

    Holderfield, M., Nagel, T.E. & Stuart, D.D. Br. J. Cancer 111, 640–645 (2014).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jeff Settleman.

Ethics declarations

Competing interests

A.J.F. and J.S. are both employees of Calico Life Sciences.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Firestone, A., Settleman, J. A three-drug combination to treat BRAF-mutant cancers. Nat Med 23, 913–914 (2017). https://doi.org/10.1038/nm.4382

Download citation

Search

Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing